Interestingly, Wnt/β-catenin genes that had previously been reported as PRMT5 targets in leukaemic stem cells3 were not differentially expressed, implying that the mechanisms by which PRMT5 regulates cancer stem cell function in different cell types are distinctive. The gene discussed is PRMT5; the disease is cancer.